Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human TDP43 ELISA Kit (AC3025)
Cat.#: ASET-1614
Specifications
Description Human TDP43 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human TDP43 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.49 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 250-4000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1983 Mouse SRD5A1 ELISA Kit (AC3394) Quantitative inquiry ASET-1465 Human Meteorin ELISA Kit (AC2876) Quantitative inquiry ASET-1369 Rat Fatty Acid Synthase ELISA Kit (AC2780) Quantitative inquiry ASET-1642 Human Laminin ELISA Kit (AC3053) Quantitative inquiry ASET-2171 Rat LIS1 ELISA Kit (AC3582) Quantitative inquiry ASET-2368 Human Somatostatin ELISA Kit (AC3779) Quantitative inquiry ASET-1044 Mouse Calretinin ELISA Kit (AC2455) Quantitative inquiry ASET-1684 Human BMAL1 ELISA Kit (AC3095) Quantitative inquiry ASET-2365 Bovine IL-6 ELISA Kit (AC3776) Quantitative inquiry ASET-1793 Human GDF11 ELISA Kit (AC3204) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket